Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01060774 · ClinicalTrials.gov registry record · Phase 4

Bupivacaine Versus Lidocaine on Inflammatory Regulation

A Phase 4 study of Pain, sponsored by University of Maryland.

Completed
Registry status
Phase 4
Development phase
11
Enrollment target
1
Study location

NCT01060774 is a Phase 4 study of Pain that has completed, run by University of Maryland. The registered enrollment target is 11 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01060774, a Phase 4 study of Pain, has completed, sponsored by University of Maryland.

COMPLETED
Registry status
Phase 4
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This study is testing a local anesthetic (numbing medicine) to suppress pain. Bupivacaine and lidocaine are FDA approved local anesthetics that may decrease pain following surgery. Patients will receive either 2% lidocaine, 0.5% bupivacaine, or placebo with epinephrine 1:200,000 as a numbing medicine at the end of root canal surgery. Small pieces of gum will be taken before and after surgery and 2 days later to analyze chemicals that may be related to pain sensation.

Conditions Studied

Interventions

  • DRUG Bupivacaine
  • DRUG Lidocaine

Study Locations (1)

Maryland

  • University of Maryland, Baltimore College of Dental Surgery - Baltimore

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2008-07
Est. Completion 2010-07
Phase Phase 4

Sponsor

University of Maryland

4 total trials

What the Registry Record Tells You About NCT01060774

The ClinicalTrials.gov registry entry for NCT01060774 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (96% lower). The listed sponsor is University of Maryland, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine is the first listed.

NCT01060774 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01060774 about?

NCT01060774 is a clinical study titled "Bupivacaine Versus Lidocaine on Inflammatory Regulation". This study is testing a local anesthetic (numbing medicine) to suppress pain. Bupivacaine and lidocaine are FDA approved local anesthetics that may decrease pain following surgery. Patients will receive either 2% lidocaine, 0.5% bupivacaine, or placebo with epinephrine 1:200,000 as a numbing medicin...

What is the current status of trial NCT01060774?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-07. Estimated completion is 2010-07.

What conditions does trial NCT01060774 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01060774?

The interventions under investigation include: Bupivacaine (DRUG), Lidocaine (DRUG).

Who is sponsoring clinical trial NCT01060774?

This trial is sponsored by University of Maryland, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01060774 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.